Cydan
Orphan Disease Therapy and Drug Accelerator.
Launch date
Employees
Market cap
-
Enterprise valuation
€124—185m (Dealroom.co estimates Oct 2017.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$16.0m | Early VC | ||
$10.0m | Early VC | ||
$34.0m | Early VC | ||
Total Funding | €54.5m |
Related Content
Recent News about Cydan
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.